We compared the efficacy of intravenous gamma globulin plus aspirin with that of aspirin alone in reducing the frequency of coronary-artery abnormalities in children with acute Kawasaki syndrome in a multicenter, randomized trial. Children randomly assigned to the gamma globulin group received intravenous gamma globulin, 400 mg per kilogram of body weight per day, for four consecutive days; both treatment groups received aspirin, 100 mg per kilogram per day, through the 14th day of illness, then 3 to 5 mg per kilogram per day. Two-dimensional echocardiograms were interpreted blindly and independently by two or more readers. Two weeks after enrollment, coronary-artery abnormalities were present in 18 of 78 children (23 percent) in the aspirin group, as compared with 6 of 75 (8 percent) in the gamma globulin group (P = 0.01). Seven weeks after enrollment, abnormalities were present in 14 of 79 children (18 percent) in the aspirin group and in 3 of 79 (4 percent) in the gamma globulin group (P = 0.005). No child had serious adverse effects from receiving gamma globulin. We conclude that high-dose intravenous gamma globulin is safe and effective in reducing the prevalence of coronary-artery abnormalities when administered early in the course of Kawasaki syndrome.
Monagle, P., Chalmers, E., Chan, A., deVeber, G., Kirkham, F., Massicotte, P., Michelson, A. D.
(2008). Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 887S-968S
[Abstract][Full Text]
Minich, L. L., Sleeper, L. A., Atz, A. M., McCrindle, B. W., Lu, M., Colan, S. D., Printz, B. F., Klein, G. L., Sundel, R. P., Takahashi, M., Li, J. S., Vetter, V. L., Newburger, J. W., for the Pediatric Heart Network Investigators,
(2007). Delayed Diagnosis of Kawasaki Disease: What Are the Risk Factors?. Pediatrics
120: e1434-e1440
[Abstract][Full Text]
Gidding, S. S.
(2007). The Importance of Randomized Controlled Trials in Pediatric Cardiology. JAMA
298: 1214-1216
[Full Text]
O'Connor, M. J., Saulsbury, F. T.
(2007). Incomplete and Atypical Kawasaki Disease in a Young Infant: Severe, Recalcitrant Disease Responsive to Infliximab. CLIN PEDIATR
46: 345-348
[Abstract]
el Karoui, K., Servais, A., Fadel, F., Jablonski, M., Fakhouri, F., Lesavre, P., Hummel, A.
(2007). Acute renal failure and febrile rash--infectious or not?. Nephrol Dial Transplant
22: 949-951
[Full Text]
Manghat, N E, Morgan-Hughes, G J, Cox, I D, Roobottom, C A
(2006). Giant coronary artery aneurysm secondary to Kawasaki disease: diagnosis in an adult by multi-detector row CT coronary angiography.. Br. J. Radiol.
79: e133-e136
[Abstract][Full Text]
Baer, A. Z., Rubin, L. G., Shapiro, C. A., Sood, S. K., Rajan, S., Shapir, Y., Romano, A., Bierman, F. Z.
(2006). Prevalence of Coronary Artery Lesions on the Initial Echocardiogram in Kawasaki Syndrome. Arch Pediatr Adolesc Med
160: 686-690
[Abstract][Full Text]
Kobayashi, T., Inoue, Y., Takeuchi, K., Okada, Y., Tamura, K., Tomomasa, T., Kobayashi, T., Morikawa, A.
(2006). Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease. Circulation
113: 2606-2612
[Abstract][Full Text]
Rosenkranz, M. E., Schulte, D. J., Agle, L. M.A., Wong, M. H., Zhang, W., Ivashkiv, L., Doherty, T. M., Fishbein, M. C., Lehman, T. J.A., Michelsen, K. S., Arditi, M.
(2005). TLR2 and MyD88 Contribute to Lactobacillus casei Extract-Induced Focal Coronary Arteritis in a Mouse Model of Kawasaki Disease. Circulation
112: 2966-2973
[Abstract][Full Text]
Ballow, M.
(2005). Clinical and investigational considerations for the use of IGIV therapy. Am J Health Syst Pharm
62: S12-S18
[Abstract][Full Text]
Simonini, G., Rose, C. D., Vierucci, A., Falcini, F., Athreya, B. H.
(2005). Diagnosing Kawasaki syndrome: the need for a new clinical tool. Rheumatology (Oxford)
44: 959-961
[Full Text]
Binstadt, B. A., Levine, J. C., Nigrovic, P. A., Gauvreau, K., Dedeoglu, F., Fuhlbrigge, R. C., Weindling, S. N., Newburger, J. W., Sundel, R. P.
(2005). Coronary Artery Dilation Among Patients Presenting With Systemic-Onset Juvenile Idiopathic Arthritis. Pediatrics
116: e89-e93
[Abstract][Full Text]
Takeshita, S., Kawamura, Y., Nakatani, K., Tsujimoto, H., Tokutomi, T.
(2005). Standard-dose and Short-term Corticosteroid Therapy in Immunoglobulin-resistant Kawasaki Disease. CLIN PEDIATR
44: 423-426
[Abstract]
Anderson, M. S., Todd, J. K., Glode, M. P.
(2005). Delayed Diagnosis of Kawasaki Syndrome: An Analysis of the Problem. Pediatrics
115: e428-e433
[Abstract][Full Text]
Ichiyama, T., Ueno, Y., Hasegawa, M., Ishikawa, Y., Matsubara, T., Furukawa, S.
(2005). Intravenous immunoglobulin does not increase Fc{gamma}RIIB expression on monocytes/macrophages during acute Kawasaki disease. Rheumatology (Oxford)
44: 314-317
[Abstract][Full Text]
Newburger, J. W., Takahashi, M., Gerber, M. A., Gewitz, M. H., Tani, L. Y., Burns, J. C., Shulman, S. T., Bolger, A. F., Ferrieri, P., Baltimore, R. S., Wilson, W. R., Baddour, L. M., Levison, M. E., Pallasch, T. J., Falace, D. A., Taubert, K. A.
(2004). Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics
114: 1708-1733
[Abstract][Full Text]
Hsieh, K.-S., Weng, K.-P., Lin, C.-C., Huang, T.-C., Lee, C.-L., Huang, S.-M.
(2004). Treatment of Acute Kawasaki Disease: Aspirin's Role in the Febrile Stage Revisited. Pediatrics
114: e689-e693
[Abstract][Full Text]
Newburger, J. W., Takahashi, M., Gerber, M. A., Gewitz, M. H., Tani, L. Y., Burns, J. C., Shulman, S. T., Bolger, A. F., Ferrieri, P., Baltimore, R. S., Wilson, W. R., Baddour, L. M., Levison, M. E., Pallasch, T. J., Falace, D. A., Taubert, K. A.
(2004). Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation
110: 2747-2771
[Abstract][Full Text]
Monagle, P., Chan, A., Massicotte, P., Chalmers, E., Michelson, A. D.
(2004). Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 645S-687S
[Abstract][Full Text]
Akikusa, J. D., Laxer, R. M., Friedman, J. N.
(2004). Intestinal Pseudoobstruction in Kawasaki Disease. Pediatrics
113: e504-e506
[Abstract][Full Text]
Meissner, H. C., Leung, D. Y. M.
(2003). Kawasaki Syndrome: Where Are the Answers?. Pediatrics
112: 672-676
[Full Text]
Baker, A. L., Gauvreau, K., Newburger, J. W., Sundel, R. P., Fulton, D. R., Jenkins, K. J.
(2003). Physical and Psychosocial Health in Children Who Have Had Kawasaki Disease. Pediatrics
111: 579-583
[Abstract][Full Text]
Saulsbury, F. T.
(2002). Comparison of High-Dose and Low-Dose Aspirin Plus Intravenous Immunoglobulin in the Treatment of Kawasaki Syndrome. CLIN PEDIATR
41: 597-601
[Abstract]
Wiles, C M, Brown, P, Chapel, H, Guerrini, R, Hughes, R A C, Martin, T D, McCrone, P, Newsom-Davis, J, Palace, J, Rees, J H, Rose, M R, Scolding, N, Webster, A D B
(2002). Intravenous immunoglobulin in neurological disease: a specialist review. J. Neurol. Neurosurg. Psychiatry
72: 440-448
[Abstract][Full Text]
Pyne, D., Ehrenstein, M., Morris, V.
(2002). The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases. Rheumatology (Oxford)
41: 367-374
[Full Text]
Kazatchkine, M. D., Kaveri, S. V.
(2001). Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin. NEJM
345: 747-755
[Full Text]
McNamara, D. M., Holubkov, R., Starling, R. C., Dec, G. W., Loh, E., Torre-Amione, G., Gass, A., Janosko, K., Tokarczyk, T., Kessler, P., Mann, D. L., Feldman, A. M.
(2001). Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy. Circulation
103: 2254-2259
[Abstract][Full Text]
Voss, L. M., Wilson, N. J., Neutze, J. M., Whitlock, R. M. L., Ameratunga, R. V., Cairns, L. M., Lennon, D. R.
(2001). Intravenous Immunoglobulin in Acute Rheumatic Fever : A Randomized Controlled Trial. Circulation
103: 401-406
[Abstract][Full Text]
Monagle, P., Michelson, A. D., Bovill, E., Andrew, M.
(2001). Antithrombotic Therapy in Children. Chest
119: 344S-370S
[Full Text]
Burns, J. C., Kushner, H. I., Bastian, J. F., Shike, H., Shimizu, C., Matsubara, T., Turner, C. L.
(2000). Kawasaki Disease: A Brief History. Pediatrics
106: 27e-27
[Abstract][Full Text]
Jayne, D.R.W., Chapel, H., Adu, D., Misbah, S., O'Donoghue, D., Scott, D., Lockwood, C.M.
(2000). Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM
93: 433-439
[Abstract][Full Text]
Han, R. K., Silverman, E. D., Newman, A., McCrindle, B. W.
(2000). Management and Outcome of Persistent or Recurrent Fever After Initial Intravenous Gamma Globulin Therapy in Acute Kawasaki Disease. Arch Pediatr Adolesc Med
154: 694-699
[Abstract][Full Text]
Han, R. K., Sinclair, B., Newman, A., Silverman, E. D., Taylor, G. W., Walsh, P., McCrindle, B. W.
(2000). Recognition and management of Kawasaki disease. CMAJ
162: 807-812
[Abstract][Full Text]
Newburger, J. W, Burns, J. C
(1999). Kawasaki disease. Vasc Med
4: 187-202
[Abstract]
Witt, M. T., Minich, L. L., Bohnsack, J. F., Young, P. C.
(1999). Kawasaki Disease: More Patients Are Being Diagnosed Who Do Not Meet American Heart Association Criteria. Pediatrics
104: 10e-10
[Abstract][Full Text]
Rhodes, J., King, M. E., Aretz, H. T.
(1998). Case 36-1998- An 11-Year-Old Girl with Fever, Hypotension, and Azotemia. NEJM
339: 1619-1626
[Full Text]
Miyagawa, M., Mochizuki, T., Murase, K., Tanada, S., Ikezoe, J., Sekiya, M., Hamamoto, K., Matsumoto, S., Niino, M.
(1998). Prognostic Value of Dipyridamole-Thallium Myocardial Scintigraphy in Patients With Kawasaki Disease. Circulation
98: 990-996
[Abstract][Full Text]
Rowley, A. H., Shulman, S. T.
(1998). Kawasaki Syndrome. Clin. Microbiol. Rev.
11: 405-414
[Abstract][Full Text]
Basma, H., Norrby-Teglund, A., McGeer, A., Low, D. E., El-Ahmedy, O., Dale, J. B., Schwartz, B., Kotb, M.
(1998). Opsonic Antibodies to the Surface M Protein of Group A Streptococci in Pooled Normal Immunoglobulins (IVIG): Potential Impact on the Clinical Efficacy of IVIG Therapy for Severe Invasive Group A Streptococcal Infections. Infect. Immun.
66: 2279-2283
[Abstract][Full Text]
Lhote, F, Cohen, P, Guillevin, L
(1998). Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus
7: 238-258
[Abstract]
Royle, J. A, Williams, K., Elliott, E., Sholler, G., Nolan, T., Allen, R., Isaacs, D.
(1998). Kawasaki disease in Australia, 1993-95. Arch. Dis. Child.
78: 33-39
[Abstract][Full Text]
Koutlas, T. C., Wernovsky, G., Bridges, N. D., Suh, E. J., Godinez, R. I., Nicolson, S. C., Spray, T. L., Gaynor, J. W.
(1997). ORTHOTOPIC HEART TRANSPLANTATION FOR KAWASAKI DISEASE AFTER RUPTURE OF A GIANT CORONARY ARTERY ANEURYSM. J. Thorac. Cardiovasc. Surg.
113: 217-218
[Full Text]
Takada, H., Kishimoto, C., Hiraoka, Y.
(1995). Therapy With Immunoglobulin Suppresses Myocarditis in a Murine Coxsackievirus B3 Model : Antiviral and Anti-inflammatory Effects. Circulation
92: 1604-1611
[Abstract][Full Text]
Groothuis, J. R., Simoes, E., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C., Tristram, D. A., Siber, G. R., Prince, G. A., Van Raden, M., Hemming, V. G., The Respiratory Syncytial Virus Immune Globulin St,
(1993). Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children. NEJM
329: 1524-1530
[Abstract][Full Text]
Murphy, D. J. JR
(1993). Kawasaki Disease: The More We Know, the Less We Know for Sure. CLIN PEDIATR
32: 51-52
Wright, W. P., Alpert, M. A., Mukerji, V., Santolin, C. J.
(1991). Coronary Artery Aneurysms A Case Study and Literature Review. ANGIOLOGY
42: 672-679
[Abstract]
